If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
INSULIN LISPRO 100 units/mL Versus HUMALOG® (insulin lispro) 100 units/mL
When transitioning from Humalog® (insulin lispro) 100 units/mL to insulin lispro 100 units/mL, no dose conversion is needed.
Do not perform dose conversion when transitioning to the generic
IL-100 3-mL Pen from Humalog 3-mL Pen
IL-100 10-mL vial from Humalog 10-mL vial, or
IL-100 3-mL Junior Pen from Humalog 3-mL Junior Pen.
For example, if a patient is transitioning from 20 units of Humalog, the patient would administer 20 units of generic IL-100.
Generic versions are identical to branded versions in terms of
3-mL Pen or 10-mL vial packaging.
Enclosed Prescribing Information
Generic = authorized generic
Humalog = Humalog® (insulin lispro injection) 100 units/mL
IL-100 = insulin lispro injection 100 units/mL
Lilly = Eli Lilly and Company
NDC = National Drug Code
Pen = KwikPen®
Date of Last Review: March 03, 2020